Tag: Central nervous system

PIPE-791 enters clinical phase: Pipeline Therapeutics’ precision approach to neuroinflammation treatment

businessnewstoday- August 1, 2023

Pipeline Therapeutics, a clinical-stage biopharmaceutical firm specializing in precision neuroregeneration, has announced the initiation of dosing for the Phase 1 clinical trial of PIPE-791 in ... Read More

Novartis acquires biotech firm DTx Pharma to gain access to FALCON platform

businessnewstoday- July 17, 2023

Swiss pharmaceutical giant Novartis has acquired DTx Pharma, a preclinical stage biotechnology company based in California renowned for its Fatty Acid Ligand Conjugated OligoNucleotide (FALCON) ... Read More

Lupin subsidiary MedQuímica buys rights to nine drugs from Bausch Health

businessnewstoday- November 29, 2022

Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights to nine drugs from Bausch Health Companies’ ... Read More

Permira to acquire Spanish pharma company Neuraxpharm from Apax Partners

pharmanewsdaily- September 23, 2020

Permira, a UK-based private equity firm, said that a company backed by its funds has agreed to acquire Neuraxpharm, a specialty pharma company focused on ... Read More

Tenzing to acquire clinical-stage pharma company Reviva Pharmaceuticals

pharmanewsdaily- July 21, 2020

Tenzing Acquisition has agreed to acquire Reviva Pharmaceuticals, a California-based clinical-stage pharma company, focused on developing therapies for addressing unmet medical needs in the areas ... Read More

US biotech company Viela Bio bags Uplizna FDA approval for NMOSD

pharmanewsdaily- June 12, 2020

Uplizna FDA approval : US biotech company Viela Bio has secured approval from the US Food and Drug Administration (FDA) for Uplizna (inebilizumab-cdon) injection for ... Read More

Alkermes to acquire Boston-based neuroscience company Rodin Therapeutics

pharmanewsdaily- November 19, 2019

Alkermes acquisition of Rodin Therapeutics : Irish biopharma company Alkermes has agreed to acquire Boston-based neuroscience company Rodin Therapeutics in a deal worth up to ... Read More

LAVENDER phase 3 clinical trial launched for trofinetide in Rett syndrome by Acadia Pharmaceuticals

pharmanewsdaily- October 31, 2019

US biopharma company Acadia Pharmaceuticals has launched the LAVENDER phase 3 clinical trial to evaluate the efficacy and safety of trofinetide for the treatment of ... Read More

Lilly bags Reyvow FDA approval for acute treatment of migraine

pharmanewsdaily- October 13, 2019

Reyvow FDA approval : Eli Lilly and Company (Lilly) has bagged approval from the US Food and Drug Administration (FDA) for Reyvow (lasmiditan) for the ... Read More